BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:08 PM
 | 
Mar 26, 2009
 |  BC Extra  |  Company News

FDA declines petition against generic Copaxone

Teva (NASDAQ:TEVA) said FDA declined to review the company's Citizen's Petition seeking to block approval of a generic version of the company's multiple sclerosis drug Copaxone glatiramer. According to the company, the agency said it...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >